A Miller School physician known for his passion in the fight against breast cancer has been honored for that work and much more on a national stage. Orlando E. Silva, M.D., J.D., associate professor of medicine and faculty member of the Jay Weiss Center for Social Medicine and Health Equity, was chosen to receive the "Outstanding Hispanic Award" at The Americano's First Annual Hispanic Forum, held in Washington, D.C.
Joined by Miller School Dean Pascal J. Goldschmidt, M.D., and UM Senior Vice President for Business and Finance Joe Natoli, more than 315 cyclists took part in this past weekend’s inaugural, tri-county Dolphins Cycling Challenge, raising over $400,000 for cancer research and treatment at the Sylvester Comprehensive Cancer Center.
Under the roof of Miami’s newest world-class hotel, South Floridians gathered 870 strong to show their commitment to helping Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine remain at the forefront of cancer research.
A new era in breast cancer research was unveiled as the Sylvester Comprehensive Cancer Center dedicated new research laboratories for the Braman Family Breast Cancer Institute. The event took place at the Miller School’s Biomedical Research Building, now home of the Braman Family Breast Cancer Institute’s research headquarters.
On Saturday, November 20, and Sunday, November 21, Team Sylvester will take to the streets along with hundreds of other cyclists and volunteers in the inaugural Dolphins Cycling Challenge to benefit the Sylvester Comprehensive Cancer Center. The Miami Dolphins Foundation chose Sylvester as the sole beneficiary of this event to raise funds and awareness for cancer research.
Surrounded by a congressman, a mayor, and dozens of business and community leaders, nearly 400 people gathered at the premiere of the newly expanded Sylvester at Deerfield Beach facility and heaped praise on the many physicians and employees in attendance.
The Braman Family Breast Cancer Institute is pleased to announce this year's Sylvester Braman Family Breast Cancer Institute's Women's Cancer League Developmental Grant Program awardees.
Researchers and physicians at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine continue to break new ground in research that benefits the medically underserved. The National Cancer Institute of the National Institutes of Health has awarded more than $4.2 million in funding to a five-year Miller School project aimed at reducing the excess rate of cervical cancer among minority women.
A group of scientists and physicians, led by Richard J. Cote, M.D., professor and chair of pathology at the University of Miami Miller School of Medicine, has developed a novel filter-based microdevice that detects and characterizes circulating tumor cells, which "could transform the way cancer is diagnosed and treated," says Cote.
A new study published online today ahead of print in _Lancet Oncology_ on its fast track shows that using dexrazoxane – an iron chelator that reduces free-radical injury in some settings – to prevent heart damage in young cancer patients during chemotherapy provides long-term cardioprotection without compromising cancer treatment.
Donning helmets and cycling gear, UM President Donna E. Shalala and Miami Dolphins CEO Mike Dee rode bikes onto the Schoninger Research Quadrangle Monday to announce a two-day, 30- to 170-mile, tri-county bike ride to benefit Sylvester Comprehensive Cancer Center this November.
When internist Stephen Bekanich, M.D., was in medical school, he wasn't interested in palliative care. But when his grandmother endured a troubling death from metastatic breast cancer nearly a decade later, he redirected his career to the burgeoning field dedicated to relieving physical symptoms and emotional distress of seriously ill patients.
Jean L. Wright, M.D., assistant professor of radiation oncology and member of the Sylvester Comprehensive Cancer Center, has been recognized as an Educator of the Year by the Association of Residents in Radiation Oncology (ARRO). The award, given to 40 educators across the nation, is presented in partnership with the American Society for Radiation Oncology (ASTRO).
Led by UM President Donna E. Shalala, a delegation of Miller School officials recently concluded a successful week of high-level meetings in Israel aimed at identifying areas of collaboration and synergy with Bar-Ilan University as Israel's largest and fastest growing university establishes the nation's fifth medical school.
Miller School researchers have found that melanoma rates among minorities in Florida differ from national trends. Scientists discovered higher incidence rates among Hispanic men and non-Hispanic black women, but lower rates among Hispanic women. The results are published in the July issue of Archives of Dermatology, one of the Journal of the American Medical Association/Archives journals.
The prostate-specific antigen (PSA) test is commonly used in men for prostate cancer screening. However, there have been concerns the test is not specific enough. Only one-third of men with elevated PSA are diagnosed with prostate cancer following a biopsy, indicating that a large proportion of patients undergo unnecessary prostate biopsy. New research conducted at Sylvester Comprehensive Cancer Center
The Sylvester Comprehensive Cancer Center proudly hosted the 11th Annual Zubrod Memorial Lecture and Cancer Research Poster Session on May 21. This year’s distinguished lecturer was Mario R. Capecchi, Ph.D., professor of biology and human genetics at Howard Hughes Medical Center at the University of Utah.
Two Miller School of Medicine faculty members were honored at the Greater Miami Chamber of Commerce Health Care Heroes Awards at Parrot Jungle Thursday afternoon. W. Jarrard Goodwin, M.D., chief medical officer of Sylvester Comprehensive Cancer Center and professor of otolaryngology, was presented the premier honor at the luncheon, the AXA Advisors Lifetime Achievement Award.
Patients battling lung and breast cancer that has metastasized to the brain currently have limited effective treatment options. This has created a critical need for the development of new therapies. Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have just received approval to begin enrolling patients...
Harnessing the immune system is emerging as one of the most promising new ways to fight cancer. Most cancer cells are eliminated by the immune system; however, over a lifetime, a few may escape this immune surveillance and lead to tumors and metastases.
The 21,000-member Papanicolaou Corps for Cancer Research has announced its annual gift to fund vital cancer research at Sylvester Comprehensive Cancer Center.
A standing-room only crowd celebrated the official dedication of The Kalish Family Endowed Chair in Stem Cell Transplantation to Krishna V. Komanduri, M.D., last week, a generous gift designed to help one of the world's leading stem cell transplant innovators fulfill his dream of curing the kind of dreadful cancers that claimed successful businessman Ronald Kalish in the prime of his life.
The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine could receive nearly $10 million for continued cancer research as a result of the 2010 legislative session. This additional funding approved by the state House and Senate will enable Sylvester to recruit more researchers with expertise in specific areas of cancer, along with their research teams. In turn, this money will play a criti
The Sylvester Comprehensive Cancer Center wrote another chapter in its history Thursday evening, unveiling a bronze statue of its benefactor, the late Harcourt M. Sylvester Jr. A crowd of more than seventy people — including Sylvester's daughters, Jayne Malfitano and Laura Cameron — gathered in the courtyard just outside the cancer center for the event. Joan Scheiner, chairman of the Sylvester Board of Governors...
Surgeons from the Department of Otolaryngology at UHealth – the University of Miami Health System have performed the first removal of throat cancer in South Florida using a surgical robot. The operation was performed March 22nd at the University of Miami Hospital by Francisco Civantos, M.D.
Viruses are believed to be the cause of as many as 20 percent of all cancers, but some viruses can infect human cells and remain latent. To remain latent, they may have to suppress anti-viral host mechanisms, which can pave the way for cancer. The laboratory of Glen N. Barber, Ph.D., the Eugenia J. Dodson Chair in Cancer Research and leader of the Viral Oncology Program at Sylvester Comprehensive Cancer Center...
The Miller School’s Sylvester Comprehensive Cancer Center proudly hosted the American Association for Cancer Research and Kirk A. Landon and Dorothy P. Landon Foundation awards and lectures on Friday, February 26, with Kirk Landon on hand to personally congratulate the winners.
In many cancers, scientists have discovered that key gene regulators which normally control cell growth have either been turned off or mutated. That change in the regular pattern then allows unrestricted cell production and the creation of tumors. Sylvester researchers have discovered exactly how one critical regulator affects a transcription factor that is consistently turned on in most cancers.
In most cases, patients with recurrent, late-stage squamous cell carcinoma of the head and neck are facing a disease that is incurable. The vast majority of patients do not respond to standard therapies after a recurrence, and even if they do, the median survival is only four to six months. Those factors point to a clear need for improved therapies.